Stimulation of hematopoiesis by ex vivo activated immune cells

Patent Number: 7048922

This patent covers a clinically applicable method of increasing hematopoiesis through administration of activated peripheral blood mononuclear cells. The ability of these cells to secrete hematopoietic stimulatory cytokines is well established, however the inventor is actually claiming a method of using such ex vivo activated cells for treatment of a patient. The patent has 1 independent claim that covers a method of treatment. A potentially interesting application of this technology would be administration of an "off-the -shelf" activated lymphocyte product for patients post bone marrow transplant or post chemotherapy.

View this patent on the USPTO website.